Advertisement

FDA Approves Sublingual Ragweed Allergy Treatment — Physician’s First Watch

Medical News |
April 18, 2014

FDA Approves Sublingual Ragweed Allergy Treatment

By the Editors

The FDA has approved Ragwitek to treat hay fever, with and without conjunctivitis, caused by short ragweed pollen. The pill, to be taken sublingually, contains an extract of short ragweed pollen.

Adults should take Ragwitek daily for 12 weeks before ragweed pollen season begins and should continue to do so during the season. It will contain a boxed warning alerting patients of the potential for severe allergic reactions.

Reader Comments (1)

Jack Eisert Physician, Dermatology, 12evergreen way,sleepy hollow,ny

I am aware of patient need for this.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement